i'll go with the smart money, page-7

Onshow better go re-read the notices. Looks to me like directors buying up, bar the 1 we know (who you are guessing about why selling). As for the technology, it has FDA approval and management are working on distribution plus getting it recognised by insurance company's to allow cost re-imbursment. I think the fact that they have been able to keep getting cap shows commitment. Plus I think the name is great and the fact they have IP on it plus the WheezeRate reading, looks solid.